US2016158302A1PendingUtilityA1
Regulation of Brain Biogenic Amines Associated with Depression by a Formulation from Botanical Source
Est. expiryDec 6, 2034(~8.4 yrs left)· nominal 20-yr term from priority
A61K 36/185A61K 45/06A61K 36/53A61K 36/63
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are anti depressant and anxiolytic herbal formulations including: 225-450 mg of Nyctanthes arbortristis , 250-550 mg Ocimum tenuiflorum , 200-450 mg Hippophae salcifolia , and optionally additives selected from minerals, vitamins, salt, filler and binder. Also provided are methods of making such formulations and methods of using such formulations for treating or improving brain function.
Claims
exact text as granted — not AI-modified1 . An anti depressant and anxiolytic herbal formulation comprising:
225-450 mg of Nyctanthes arbortristis; 250-550 mg Ocimum tenuiflorum; 200-450 mg Hippophae salcifolia ; and optionally additives selected from minerals, vitamins, salt, filler and binder.
2 . The herbal formulation as claimed in claim 1 , wherein the said formulation comprises whole plant of Nyctanthes arbortristis , whole plant of Ocimum tenuiflorum and only leaves and fruits of Hippophae salcifolia.
3 . The herbal formulation as claimed in claim 1 wherein the amount of each of the components are:
325 mg Nyctanthes arbortristis;
350 mg of Ocimum tenuiflorum;
275 mg of Hippophae salcifolia.
4 . A process for the preparation of a herbal formulation comprising:
grinding a portion of each of Nyctanthes arbortristis, Ocimum tenuiflorum , and Hippophae salcifolia , to provide ground herbal matter, subjecting the ground herbal matter to the step of extraction using water to provide a: filtering the extracts to provide a filtered product; subjecting the filtered product to the step of distillation under vacuum; evaporating the water and drying the filtered product under vacuum; and grounding and sieving the filtered product.
5 . The process as claimed in claim 4 , wherein the temperature at time of extraction is 70°-80° C. and the extraction process lasts for a period of 3-4 hrs.
6 . The process as claimed in claim 4 , wherein the temperature of distillation is 65° C.
7 . (canceled)
8 . (canceled)
9 . A method of treating depression in a patient comprising administering to a patient in need thereof a formulation containing extract of Nyctanthes arbortristis and Hippophae salciofolia in an amount effective to promote sleep pattern and improve wake-cycle and depression symptoms.
10 . (canceled)
11 . (canceled)
12 . A method of treating depression in a patient comprising administering to a patient in need thereof a formulation comprising Ocimum tenuiflorum and Hippophae salcifolia in an amount effective to ameliorate symptoms of depression in the patient.
13 . The method of claim 12 , wherein administering the formulation improves brain functional impairment, maintains hippocampal volume, and/or enhances neuronal plasticity in the patient.
14 . The method of claim 12 , wherein administering the formulation improves sleep quality in the patient.
15 . A method of treating depression in a patient comprising administering to a patient in need thereof a formulation comprising Nyctanthes arbortrist and Ocimum tenuiflorum in an amount effective to ameliorate symptoms of depression in the patient.
16 . The method of claim 15 , wherein administering the formulation reduces anxiety and/or phobic reactions in the patient.
17 . The method of claim 15 , wherein administering the formulation improvise diffusion and hallucinations in the patient.
18 . The method of claim 15 , wherein administering the formulation enhances immunity and/or improves fatigue in the patient.Join the waitlist — get patent alerts
Track US2016158302A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.